MedTrace Logo

Mechanisms Underlying Cardiovascular Consequences Associated With COVID-19 and Long COVID

NCT06427512 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2024-05-24

No results posted yet for this study

Summary

AIM 1. Characterize cardiovascular phenotypes of long COVID by cardiopulmonary, meta-bolic, and cardiac mechanical/physiological responses to exercise and microvascular vasomotor function.

AIM 2. Identify intercellular signaling between immune cells and cardiac cells associated with microvascular phenotypes of long COVID.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Emily Tsai, MD · Florence Irving Associate Professor of Medicine, Dept of Medicine Cardiology

Eligibility

Min Age
19 Years
Max Age
74 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-31
Primary Completion
2025-03-31
Completion
2025-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06427512 on ClinicalTrials.gov